Cervical screening provider lead (CSPL) actions checklist
Updated 26 September 2024
Applies to England
The following information is a suggested checklist of actions for the cervical screening provider lead (CSPL) during the audit process leading up to the offer of disclosure to a woman who has been diagnosed with cervical cancer.
The CSPL should:
- receive the cervical cancer diagnosis information from the histology laboratory
- log the case and add it to the agenda of the colposcopy multidisciplinary team (MDT) meeting
- initiate the audit of invasive cervical cancer, and contact the relevant parties (this may include one or more of cytology, histology and colposcopy departments)
- make contact with the relevant clinician at the treating organisation (if the individual is being treated at a different organisation to where their diagnosis was made)
- complete the audit
- inform the SQAS at the earliest opportunity if there is a possible screening incident
- present the audit results at the colposcopy MDT, where a decision is made regarding the classification of the case, including whether duty of candour applies
- ensure agreement is made at the MDT regarding who will be the disclosing clinician
- inform the treating organisation of the results of the review
- finalise the summary report, incorporating the final case assessment, and send to the disclosing clinician
- send the completed audit to the Screening Quality Assurance Service (SQAS)
- ensure the disclosure offer letter and any reminder letters are sent by the diagnosing organisation’s clinical team
- ensure the treating organisation is informed that disclosure has been offered
- document the end of the disclosure process when advised by the disclosing clinician
Following the episode the CSPL should:
- include any local outcomes and learning in their annual report - this report will be discussed at the local programme board following approval by the organisation, enabling outcomes and learning to be captured by the SQAS
- carry out an annual audit of offers of disclosure to individuals diagnosed with cervical cancer